Ningbo MedicalSystem Biotechnology Co Ltd Working Capital to Net Assets Ratio
Ningbo MedicalSystem Biotechnology Co Ltd working capital to net assets ratio. Ningbo MedicalSystem Biotechnology Co Ltd (300439) has a Working Capital to Net Assets ratio of 43.3% as of September 2025. Working capital of CN¥1.28 Billion (current assets of CN¥1.88 Billion minus current liabilities of CN¥602.92 Million) is measured against net assets of CN¥2.95 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Ningbo MedicalSystem Biotechnology Co Lt to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Ningbo MedicalSystem Biotechnology Co Ltd (2011–2024)
Working capital to net assets ratio of Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024. This chart shows how Ningbo MedicalSystem Biotechnology Co Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 43.3%, reflecting working capital of CN¥1.28 Billion against net assets of CN¥2.95 Billion CNY. See Ningbo MedicalSystem Biotechnology Co Lt (300439) liquidity interval to measure how many days the company can operate on defensive assets alone.
Ningbo MedicalSystem Biotechnology Co Ltd Working Capital to Net Assets Ratio by Year (2011–2024)
Ningbo MedicalSystem Biotechnology Co Ltd working capital to net assets ratio by year from 2011 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Ningbo MedicalSystem Biotechnology Co Lt total assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 39.4% | CN¥1.16 Billion | CN¥2.93 Billion | CN¥1.82 Billion | CN¥667.44 Million | ▼ -4.9 pp |
| 2023 | 44.3% | CN¥1.20 Billion | CN¥2.71 Billion | CN¥1.90 Billion | CN¥699.13 Million | ▲ +1.1 pp |
| 2022 | 43.3% | CN¥1.09 Billion | CN¥2.52 Billion | CN¥2.07 Billion | CN¥981.30 Million | ▲ +3.6 pp |
| 2021 | 39.7% | CN¥948.74 Million | CN¥2.39 Billion | CN¥2.01 Billion | CN¥1.06 Billion | ▲ +29.0 pp |
| 2020 | 10.7% | CN¥180.40 Million | CN¥1.69 Billion | CN¥1.57 Billion | CN¥1.39 Billion | ▲ +5.5 pp |
| 2019 | 5.2% | CN¥72.07 Million | CN¥1.39 Billion | CN¥2.13 Billion | CN¥2.06 Billion | ▼ -4.5 pp |
| 2018 | 9.7% | CN¥221.10 Million | CN¥2.27 Billion | CN¥2.38 Billion | CN¥2.16 Billion | ▼ -17.3 pp |
| 2017 | 27.0% | CN¥618.37 Million | CN¥2.29 Billion | CN¥2.40 Billion | CN¥1.78 Billion | ▼ -7.5 pp |
| 2016 | 34.5% | CN¥630.99 Million | CN¥1.83 Billion | CN¥1.76 Billion | CN¥1.13 Billion | ▼ -44.4 pp |
| 2015 | 78.9% | CN¥1.02 Billion | CN¥1.29 Billion | CN¥1.14 Billion | CN¥128.29 Million | ▲ +21.9 pp |
| 2014 | 57.0% | CN¥236.66 Million | CN¥415.13 Million | CN¥432.37 Million | CN¥195.71 Million | ▲ +6.2 pp |
| 2013 | 50.8% | CN¥156.66 Million | CN¥308.32 Million | CN¥314.75 Million | CN¥158.09 Million | ▲ +6.5 pp |
| 2012 | 44.3% | CN¥89.76 Million | CN¥202.58 Million | CN¥216.42 Million | CN¥126.66 Million | ▲ +5.9 pp |
| 2011 | 38.4% | CN¥42.59 Million | CN¥110.84 Million | CN¥110.76 Million | CN¥68.17 Million | — |